Texas Vanguard Oil Company releases 2nd Quarter 2014

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Texas Vanguard Oil Company releases 2nd Quarter 2014 Unaudited Interim Financial Statements

Austin, TX, Aug. 13, 2014 (GLOBE NEWSWIRE) -- Texas Vanguard Oil Company has prepared its second quarter 2014 Unaudited Finanical Information ending June 30, 2014, and its Condensed Financial Statements are as follows:

 

TEXAS VANGUARD OIL COMPANY

Condensed Balance Sheets

Assets  
    June 30,     December 31,  
    2014     2013  
    (Unaudited)     (Audited)  
Current assets:            
   Cash and cash equivalents (including certificates of deposit of
   $250,000 in 2014 and $1,250,000 pledged in 2013)
  $ 18,635,524     $ 12,212,690  
   Trade accounts receivable     94,705       193,395  
   Prepaid expense     89,429       100,813  
   Note receivable     -0-       8,000,000  
   Total current assets     18,819,658       20,506,898  
Property and equipment, at cost:                
   Oil and gas properties - successful efforts method of accounting     3,783,536       3,926,210  
   Office furniture and vehicles     156,871       156,871  
      3,940,407       4,083,081  
   Less accumulated depreciation, depletion and amortization     (1,658,575 )     (1,792,771 )
   Total property and equipment, net     2,281,832       2,290,310  
Other assets     1,000       1,000  
   TOTAL ASSETS   $ 21,102,490     $ 22,798,208  
                 
Liabilities and Stockholders' Equity  
                 
Current liabilities:                
  Trade accounts payable    $ 201,564      $ 477,528  
   Taxes payable     1,520,510       770,943  
   Deferred federal income tax liability     -0-       1,757,882  
   Asset retirement obligation, current portion     12,750       6,678  
Notes payable     -0-       150,000  
   Total current liabilities     1,734,824       3,163,031  
                 
Asset retirement obligation, less current portion     92,239       93,089  
   Total liabilities     1,827,063       3,256,120  
Stockholders' equity:                
   Common stock, par value $.05; authorized 12,500,000 shares;
    1,416,587 issued and outstanding in 2014 and 2013, respectively
    70,828       70,828  
   Additional paid-in capital     1,888,528       1,888,528  
   Accumulated earnings     17,316,071       17,582,732  
   Total stockholders' equity     19,275,427       19,542,088  
                 
   TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY   $ 21,102,490     $ 22,798,208  
                   

See accompanying notes to condensed financial statements.

TEXAS VANGUARD OIL COMPANY

Condensed Statements of Earnings

(Unaudited)

    Three months ended     Six months ended  
    June 30,     June 30,  
    2014     2013     2014     2013  
Revenue:                        
   Operating revenue   $ 222,312     $ 1,256,864     $ 442,572     $ 2,726,030    
   Other income     2,974       13,444       7,159       26,563    
   Total revenue     225,286       1,270,308       449,731       2,752,593    
Costs and expenses:                                  
   Production cost     224,838       755,357       296,842       1,553,846    
   Depreciation, depletion and amortization     52,996       102,359       105,991       204,719    
   General and administrative     192,834       148,504       404,027       310,258    
   Plug and abandonment of oil and gas property     30,401       108,710       46,056       108,710    
   Interest     201       654       849       1,525    
   Doubtful account expense     -0-       59       -0-       18,743    
   Total costs and expenses     501,270       1,115,643       853,765       2,197,801    
   Earnings (loss) before taxes     (275,984)       154,665       (404,034 )     554,792    
                                   
Federal and state taxes:                                  
   Provision for federal income tax (benefit)     (93,835)       50,103       (137,372)       183,248    
   Provision for state margin tax     -0-       7,304       -0-       15,827    
   Net earnings (loss)   $ (182,149)     $ 97,258     $ (266,662)     $ 355,717    
                                   
Weighted average number of shares outstanding     1,416,587       1,416,587       1,416,587       1,416,587    
                                   
Basic earnings (loss) per share   $ (.13)     $ .07     $ (.19)     $ .25    
Diluted earnings (loss) per share   $ (.13)     $ .07     $ (.19)     $ .25    
                                                         

TEXAS VANGUARD OIL COMPANY

Condensed Statements of Cash Flows

(Unaudited)

    Six months ended  
    June 30,  
    2014     2013  
Net cash provided by (used in) operating activities   $ (1,315,917)     $ 592,263  
                 
Cash flows used in investing activities:                
                 
   Additions to oil and gas properties     (111,249)       (47,450)  
   Proceeds from collection of note receivable     8,000,000       -0-  
Net cash provided by (used in) investing activities     7,888,751       (47,450 )
                 
Net cash used in financing activities     (150,000)       ---  
Net change in cash and cash equivalents     6,422,834       544,813  
                 
Cash and cash equivalents at beginning of period     12,212,690       9,036,449  
Cash and cash equivalents at end of period   $ 18,635,524     $ 9,581,262  

See accompanying notes to condensed financial statements.

TEXAS VANGUARD OIL COMPANY

Notes to Condensed Financial Statements

(Unaudited)

June 30, 2014

Note 1:   Basis of Financial Statement Presentation

These unaudited condensed financial statements should be read in the context of the financial statements and notes thereto filed with the Securities and Exchange Commission in the Company's 2013 Annual Report on Form 10-K. 

Note 2:    Oil and Gas Properties

Texas Vanguard Oil Company (the "Company") follows the "successful efforts" method of accounting for oil and gas exploration and production operations. Accordingly, costs incurred in the acquisition and exploratory drilling of oil and gas properties are initially capitalized and either subsequently expensed if the properties are determined not to have proved reserves, or reclassified as a proven property if proved reserves are discovered.  Costs of drilling development wells are capitalized. Geological, geophysical, carrying and production costs are charged to expense as incurred.

The Company performs a periodic review for impairment of proved properties. The Company determines if impairment has occurred through either adverse changes or as a result of its periodic review for impairment. Upon abandonment of properties, the reserves are deemed fully depleted and any unamortized costs are recorded in the statement of income under impairment expense. Upon the sale of oil and gas reserves in place, costs less accumulated amortization of such property are removed from the accounts and resulting gain or loss on sale is reflected in operations. 

Impairment of unproved properties is assessed periodically and any impairment in value is currently charged to expense. Loss is recognized to the extent that such impairment is indicated. When an entire interest in an unproved property is sold, gain or loss is recognized, taking into consideration any recorded impairment.

Depreciation, depletion and amortization of proved oil and gas property costs, including related equipment and facilities, are provided using the units-of-production method.

Note 3:   Income Taxes

The Company uses the "asset and liability method" of income tax accounting, which bases the amount of current and future taxes payable on the events recognized in the financial statements and on tax laws existing at the balance sheet date.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes enactment date.

Note 4:   Statement of Cash Flows

Cash and cash equivalents as used in the Condensed Statements of Cash Flows include cash in banks and certificates of deposits owned.

Note 5:   Recently Issued Accounting Standards

The Company has reviewed the updates issued by the Financial Accounting Standards Board (FASB) during the six-month period ended June 30, 2014, and determined that the updates are either not applicable to the Company or will not have a material impact upon the Company.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading